DIVE/DPV registries: benefits and risks of analog insulin use in individuals 75 years and older with type 2 diabetes mellitus

DIVE/DPV registries: benefits and risks of analog insulin use in individuals 75 years and older with type 2 diabetes mellitus

Introduction The aims of this study were to characterize insulin-treated individuals aged ≥75 years with type 2 diabetes using basal insulin analogs (BIA) or regular insulins (human insulin (HI)/neutral protamine Hagedorn (NPH)) and to compare the benefits and risks.Research design and methods The a...

Disgrifiad llawn

Manylion Llyfryddiaeth
Prif Awduron: Peter Bramlage, Sascha R Tittel, Gesine van Mark, Reinhard Welp, Jörg Gloyer, Stefan Sziegoleit, Ralf Barion, Peter M Jehle, Dieter Erath, Stefanie Lanzinger
Fformat: Erthygl
Iaith:English
Cyhoeddwyd: BMJ Publishing Group 2021-03-01
Cyfres:BMJ Open Diabetes Research & Care
Mynediad Ar-lein:https://drc.bmj.com/content/9/1/e002215.full

Rhyngrwyd

https://drc.bmj.com/content/9/1/e002215.full

Eitemau Tebyg